Protalix Biotherapeutics, Inc. (PLX)
1.75
+0.01
(+0.57%)
USD |
NYAM |
Dec 09, 16:00
1.75
0.00 (0.00%)
Pre-Market: 07:59
Protalix Biotherapeutics Market Cap: 140.74M for Dec. 9, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| GlucoTrack, Inc. | 160.97M |
| PAVmed, Inc. | 10.17M |
| AIM ImmunoTech, Inc. | 1.139M |
| Perspective Therapeutics, Inc. | 187.33M |
| Armata Pharmaceuticals, Inc. | 223.06M |
Market Cap Related Metrics
| PE Ratio | 25.18 |
| PS Ratio | 2.225 |
| Price to Book Value | 2.66 |
| Price | 1.75 |
| Earnings Yield | 3.97% |
| Operating PE Ratio | 21.61 |
| Normalized PE Ratio | 25.18 |